These mutants showed good avidity and thermal stability for selective binding to TNFR1; using the arthritis murine model, muteins in plasma have an extended half-life, and regulatory T cells are increased compared to etanercept [138,139,140,141,142,152]. The gene discussed is TNFRSF1A; the disease is arthritic joint disease.